CMPI.org

In the News

Reduce drug prices by eliminating PBM rebates

02/15/2017 12:00 AM | The Hill

Controlling Cost Through Value

02/10/2017 12:00 AM | Morning Consult

President Trump misunderstands what government drug price negotiations entail

02/01/2017 12:00 AM | Washington Examiner

Keep the feds out of drug pricing

12/18/2016 12:00 AM | USA Today

There is a Sure Cure, But It's Not Covered by Your Health Insurance Plan

09/17/2016 12:00 AM | Newsweek

Pitts on EpiPen outrage: 'Perfect storm of stupidity'

08/24/2016 12:00 AM | CNBC

Superbug Nightmare: The Danger of Taking Too Many Antibiotics

08/23/2016 12:00 AM | CBN News

On Assignment: Bitter Pill

06/17/2016 12:00 AM | NBC Dateline

360 Degree Global Trade and the Urgent Need for the Trans-Pacific Partnership

05/11/2016 12:00 AM | CMPI

FDA takes step to improve generic drug competition

03/15/2016 12:00 AM | Marketplace

Single-payer health care unworkable, too costly

03/07/2016 12:00 AM | Philadelphia Inquirer

Congress must protect vital drug patents from Wall Street attacks

01/14/2016 12:00 AM | Morrow County Sentinel

James P. Pinkerton, Cures Strategy founder, Fox News Analyst, and Reagan White House alumni, Joins CMPI

01/05/2016 12:00 AM | CMPI

States copying market-based Medicare plan

12/03/2015 12:00 AM | Philly.com

Obamacare's slippery slope to single-payer system

12/03/2015 12:00 AM | CNBC

Outlook 2014: Capitol Commotion

12/02/2015 12:00 AM | Medical Marketing and Media

Hillary’s vaccine price plan didn’t work the first time for a reason

10/18/2015 12:00 AM | New York Post

Why People Don't Trust Drug Makers

09/24/2015 12:00 AM | New York Post

‘Patent Death Squads’ vs. Innovation

06/10/2015 12:00 AM | The Wall Street Journal

NYTimes Letter to the Editor: Drug Shortages Continue to Vex

02/10/2015 12:00 AM |

Previous
1
...
7
8
9
10
11
Next

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

STAT
03/03/2020 12:00 AM

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

STAT
10/17/2024 12:00 AM

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub... Read more

Tort bar’s newest collateral damage: Preterm babies

The Washington Times
07/02/2024 12:00 AM

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more

Read all News